Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date - Medical Daily

Latest News About Osivax and GC Biopharma team up on next-generation flu vaccine

Osivax and GC Biopharma revealed a strategic collaboration aimed at developing a new-generation influenza vaccine. The vaccine aims to combine OVX836 and GC FLU. Osivax obtained rights for pursuing a combo shot.

Older adults face four vaccine decisions this fall, while the federal schedule continues to carry a 2025 date. Flu and pneumonia deaths have dropped for 25 years, but one American age group saw an increase.

Sources & References